Short Interest in Lotus Pharmaceuticals Inc. (OTCMKTS:LTUS) Declines By 56.9%

Lotus Pharmaceuticals Inc. (OTCMKTS:LTUS) saw a large decrease in short interest in May. As of May 29th, there was short interest totaling 7,566 shares, a decrease of 56.9% from the May 14th total of 17,566 shares. Based on an average daily volume of 10,000 shares, the short-interest ratio is presently 0.8 days. Approximately 0.0% of the company’s shares are sold short.

Lotus Pharmaceuticals Stock Performance

Shares of Lotus Pharmaceuticals stock traded down $0.00 on Friday, hitting $0.00. 28,000 shares of the company’s stock traded hands, compared to its average volume of 2,463. Lotus Pharmaceuticals has a one year low of $0.00 and a one year high of $0.01.

About Lotus Pharmaceuticals

Lotus Pharmaceuticals, trading under the symbol LTUS on the OTC Market, is a Taiwan-based pharmaceutical company specializing in the research, development, manufacturing and marketing of prescription medications. The company’s core operations encompass both the production of a broad range of generic drugs and the advancement of novel compounds aimed at therapeutic areas such as oncology, central nervous system disorders, cardiovascular diseases and anti-infective treatments.

Lotus Pharmaceuticals offers multiple dosage forms, including tablets, capsules, injectables and sterile preparations, to meet the needs of hospital and retail pharmacy channels.